Does TILSOTOLIMOD Cause Malignant neoplasm progression? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Malignant neoplasm progression have been filed in association with TILSOTOLIMOD. This represents 7.7% of all adverse event reports for TILSOTOLIMOD.
5
Reports of Malignant neoplasm progression with TILSOTOLIMOD
7.7%
of all TILSOTOLIMOD reports
5
Deaths
5
Hospitalizations
How Dangerous Is Malignant neoplasm progression From TILSOTOLIMOD?
Of the 5 reports, 5 (100.0%) resulted in death, 5 (100.0%) required hospitalization, and 1 (20.0%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TILSOTOLIMOD. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does TILSOTOLIMOD Cause?
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)